首页> 外文期刊>Oxidative Medicine and Cellular Longevity >PGC-1α, Inflammation, and Oxidative Stress: An Integrative View in Metabolism
【24h】

PGC-1α, Inflammation, and Oxidative Stress: An Integrative View in Metabolism

机译:PGC-1α,炎症和氧化应激:新陈代谢的整合视图

获取原文
           

摘要

Peroxisome proliferator-activated receptor-γ coactivator (PGC)-1α is a transcriptional coactivator described as a master regulator of mitochondrial biogenesis and function, including oxidative phosphorylation and reactive oxygen species detoxification. PGC-1α is highly expressed in tissues with high energy demands, and it is clearly associated with the pathogenesis of metabolic syndrome and its principal complications including obesity, type 2 diabetes mellitus, cardiovascular disease, and hepatic steatosis. We herein review the molecular pathways regulated by PGC-1α, which connect oxidative stress and mitochondrial metabolism with inflammatory response and metabolic syndrome. PGC-1α regulates the expression of mitochondrial antioxidant genes, including manganese superoxide dismutase, catalase, peroxiredoxin 3 and 5, uncoupling protein 2, thioredoxin 2, and thioredoxin reductase and thus prevents oxidative injury and mitochondrial dysfunction. Dysregulation of PGC-1α alters redox homeostasis in cells and exacerbates inflammatory response, which is commonly accompanied by metabolic disturbances. During inflammation, low levels of PGC-1α downregulate mitochondrial antioxidant gene expression, induce oxidative stress, and promote nuclear factor kappa B activation. In metabolic syndrome, which is characterized by a chronic low grade of inflammation, PGC-1α dysregulation modifies the metabolic properties of tissues by altering mitochondrial function and promoting reactive oxygen species accumulation. In conclusion, PGC-1α acts as an essential node connecting metabolic regulation, redox control, and inflammatory pathways, and it is an interesting therapeutic target that may have significant benefits for a number of metabolic diseases.
机译:过氧化物体增殖物激活的受体-γ共粘膜(PGC)-1α是称为线粒体生物发生和功能的主调节剂的转录共觉,包括氧化磷酸化和反应性氧物种排毒。 PGC-1α在具有高能量需求的组织中高度表达,并且与代谢综合征的发病机制及其主要并发症包括肥胖,2型糖尿病,心血管疾病和肝脏脂肪变性显然。我们在此述评通过PGC-1α调节的分子途径,其与炎症反应和代谢综合征连接氧化应激和线粒体代谢。 PGC-1α调节线粒体抗氧化基因的表达,包括锰超氧化物歧化酶,过氧化氢酶,过氧化嗪3和5,脱蛋白2,硫氧吡啶2和硫氧嗪还原酶,从而防止氧化损伤和线粒体功能障碍。 PGC-1α的缺点改变了细胞中的氧化还原性稳态,加剧了炎症反应,通常伴随着代谢紊乱。在炎症期间,低水平的PGC-1α下调线粒体抗氧化基因表达,诱导氧化应激,促进核因子Kappa B活化。在代谢综合征中,其特征在于慢性低等级的炎症,PGC-1α的失调通过改变线粒体功能和促进反应性氧物质积聚来改变组织的代谢性质。总之,PGC-1α充当连接代谢调节,氧化还原控制和炎症途径的基本节点,并且是一种有趣的治疗靶标,可能对许多代谢疾病具有显着益处。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号